Interferon beta and the cytokine trail - Where are we going?

被引：4

作者：

Moses, H ^{[1
]}

Sriram, S ^{[1
]}

机构：

[1] Vanderbilt Univ, Ctr Med, Dept Neurol, Div Neuroimmunol, Nashville, TN 37232 USA

来源：

NEUROLOGY | 1999年 / 52卷 / 09期

关键词：

D O I：

10.1212/WNL.52.9.1729

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：1729 / 1730

页数：2

共 8 条

[1] Interferon beta-1b treatment modulates TNFα and IFNγ spontaneous gene expression in MS [J].

Gayo, A ;

Mozo, L ;

Suarez, A ;

Tuñón, A ;

Lahoz, C ;

Gutiérrez, C .

NEUROLOGY, 1999, 52 (09) :1764-1770

[2] Primary demyelination in transgenic mice expressing interferon-gamma [J].

Horwitz, MS ;

Evans, CF ;

McGavern, DB ;

Rodriguez, M ;

Oldstone, MBA .

NATURE MEDICINE, 1997, 3 (09) :1037-1041

[3] INTRATHECAL INTERFERON REDUCES EXACERBATIONS OF MULTIPLE-SCLEROSIS [J].

JACOBS, L ;

OMALLEY, J ;

FREEMAN, A ;

EKES, R .

SCIENCE, 1981, 214 (4524) :1026-1028

[4] Natural killer cells in relapsing-remitting MS -: Effect of treatment with interferon β-1B [J].

Kastrukoff, LF ;

Morgan, NG ;

Zecchini, D ;

White, R ;

Petkau, AJ ;

Satoh, J ;

Paty, DW .

NEUROLOGY, 1999, 52 (02) :351-359

[5] CLINICAL-TRIALS OF INTERFERONS IN MULTIPLE-SCLEROSIS - WHAT HAVE WE LEARNED [J].

PANITCH, HS ;

BEVER, CT .

JOURNAL OF NEUROIMMUNOLOGY, 1993, 46 (1-2) :155-164

[6]

PANITCH HS, 1987, LANCET, V1, P893

[7] In vivo effects of interferon beta-1a on immunosuppressive cytokines in multiple sclerosis [J].

Rudick, RA ;

Ransohoff, RM ;

Lee, JC ;

Peppler, R ;

Yu, M ;

Mathisen, PM ;

Tuohy, VK .

NEUROLOGY, 1998, 50 (05) :1294-1300

[8] TUMOR NECROSIS FACTOR MEDIATES MYELIN AND OLIGODENDROCYTE DAMAGE INVITRO [J].

SELMAJ, KW ;

RAINE, CS .

ANNALS OF NEUROLOGY, 1988, 23 (04) :339-346

← 1 →